DK Life Science Co., Ltd. (KOSDAQ:303810)
South Korea flag South Korea · Delayed Price · Currency is KRW
9,080.00
+100.00 (1.11%)
Jul 21, 2025, 3:30 PM KST

DK Life Science Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Debt / Equity Ratio
0.350.430.490.460.280.07
Upgrade
Debt / EBITDA Ratio
2.432.564.034.812.550.47
Upgrade
Debt / FCF Ratio
13.907.01----
Upgrade
Asset Turnover
-0.710.700.690.761.13
Upgrade
Inventory Turnover
-2.522.753.454.907.68
Upgrade
Quick Ratio
1.681.110.981.091.031.57
Upgrade
Current Ratio
2.341.841.621.721.461.91
Upgrade
Return on Equity (ROE)
-2.22%4.46%4.90%7.45%7.16%
Upgrade
Return on Assets (ROA)
-4.02%3.10%2.49%3.16%5.41%
Upgrade
Return on Capital (ROIC)
-5.05%3.86%3.27%4.58%7.83%
Upgrade
Return on Capital Employed (ROCE)
8.20%9.30%7.40%5.40%7.30%11.20%
Upgrade
Buyback Yield / Dilution
-1125.53%-14.52%-900.58%-0.01%2.05%-2.09%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.